Pulmonx Corporation (LUNG)
Automate Your Wheel Strategy on LUNG
With Tiblio's Option Bot, you can configure your own wheel strategy including LUNG - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol LUNG
- Rev/Share 2.1893
- Book/Share 1.9439
- PB 1.6462
- Debt/Equity 0.7332
- CurrentRatio 4.9685
- ROIC -0.4356
- MktCap 128824000.0
- FreeCF/Share -0.8575
- PFCF -3.7601
- PE -2.2394
- Debt/Assets 0.3778
- DivYield 0
- ROE -0.6369
- Rating D+
- Score 1
- Recommendation Strong Sell
- P/E Score 1
- DCF Score 1
- P/B Score 2
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Initiation | LUNG | D. Boral Capital | -- | Buy | -- | $17 | March 10, 2025 |
| Downgrade | LUNG | Citigroup | Buy | Neutral | $17 | $7.5 | Dec. 11, 2024 |
News
Pulmonx Corporation (LUNG) Q4 2024 Earnings Call Transcript
Published: February 19, 2025 by: Seeking Alpha
Sentiment: Neutral
Pulmonx Corporation (NASDAQ:LUNG ) Q4 2024 Results Conference Call February 19, 2025 4:30 PM ET Company Participants Elizabeth Sparicio - Investor Relations Steve Williamson - President and Chief Executive Officer Mehul Joshi - Chief Financial Officer Conference Call Participants Frank Takkinen - Lake Street Capital Markets Jon Young - Canaccord Larry Biegelsen - Wells Fargo Joanne Wuensch - Citi Joseph Downing - Piper Sandler Operator Ladies and gentlemen, thank you for standing by. Welcome to Pulmonx Fourth Quarter 2024 Earnings Conference Call.
Read More
About Pulmonx Corporation (LUNG)
- IPO Date 2020-10-01
- Website https://pulmonx.com
- Industry Medical - Devices
- CEO Mr. Steven S. Williamson
- Employees 291